A study by Children's Hospital of Philadelphia researchers found that elementary age children are more likely to experience concussions during recreation and other non-sport activities. These injuries often lead to longer recovery times due to delayed specialist care. The findings highlight the need for education and awareness about co...
Researchers from Children's Hospital of Philadelphia found that two assessments, Leiter-3 and Vineland Adaptive Behavior Scale, can help measure cognitive function in children with Aicardi Goutières Syndrome. The study revealed that a subset of patients scored within a normal IQ range, paving the way for future clinical trial design.
A newly developed adolescent health questionnaire has been successfully adapted across pediatric primary care, increasing discussions about sensitive topics such as tobacco use, sexual behavior, and mental health. The questionnaire has improved data collection rates, with up to 95% of visit records capturing information on these topics.
A new screener tool helped families enroll in WIC and SNAP programs, leading to better health outcomes. The tool was successful in connecting 21 out of 56 families who requested benefits application support, highlighting its potential to improve access to nutrition resources.
Researchers from Children's Hospital of Philadelphia have identified a causal genetic variant strongly associated with childhood obesity. The study highlights the importance of the hypothalamus in regulating food intake and provides new insights into potential therapeutic targets.
A phase 3 clinical trial found that 96.7% of patients did not experience severe vaso-occlusive crises, and all remained hospitalization-free for at least one year after receiving the gene therapy CASGEVY.
Researchers at Children's Hospital of Philadelphia have discovered the underlying biology behind Fontan-associated liver disease, a condition affecting thousands of patients with single ventricle congenital heart disease. The study identified key cell-type specific changes in livers and potential therapeutic targets, including Activins...
A large study of over 27,000 pediatric patients found that SARS-COV-2 infection does not increase the risk of asthma development. However, children with known risk factors for asthma were more likely to associate with new SARS-COV-2 diagnoses.
Researchers at Children's Hospital of Philadelphia and Stanford Medicine discovered the FOXO1 protein plays a crucial role in controlling CAR T cell longevity. The study found that FOXO1 enhances the survival and function of CAR T cells, leading to more effective cancer treatment.
Researchers at Children's Hospital of Philadelphia found that teens and young adults with mood disorders are 30% less likely to obtain their driver’s license compared to peers without such disorders. These youths also experienced a slightly elevated risk of crashing, particularly when newly licensed.
Researchers identified nicotinamide adenine dinucleotide (NAD) as a key component of T cell receptor metabolic reprogramming, enabling rapid immune cell division. This discovery may lead to improved vaccine strategies and enhanced responses in cell-based therapies for cancer treatment.
Researchers found that pre-existing mental health diagnoses lead to a greater emotional burden and prolonged recovery time after a concussion. The study also discovered a 'dose-response' effect, where more mental health diagnoses correlate with increased emotional symptoms and longer recovery periods. Boys with prolonged recovery exper...
A large retrospective study found that vaccination against SARS-CoV-2 reduces the risk of persistent health problems in children after COVID-19. Vaccination provides stronger protection for adolescents, who are at higher risk of developing long COVID.
Researchers developed a deep-learning-based algorithm to identify tissue cellular neighborhoods (TCNs) in breast and colorectal tumors, revealing new fibroblast-enriched and granulocyte-enriched TCNs associated with high-risk disease subtypes. The study aims to better understand cancer evasion mechanisms and potential therapeutic targets.
Researchers have identified 'backbones' in HLA complexes that link to peptide-centric CARs, allowing for targeted therapies across different variants and tumor types. This breakthrough enables the design of more efficient CAR therapies for a broader range of patients with complex and difficult-to-treat cancers.
A study by Children's Hospital of Philadelphia researchers identified three novel genes associated with neurodevelopmental disorders, including developmental delay, intellectual disability, and autism. The genes' variants affecting splicing resulted in symptoms such as hypotonia, seizures, and social deficits.
A study by CHOP researchers found that seizure patterns and response to treatment can help determine epilepsy trajectories and developmental outcomes for patients with STXBP1-related disorders. The study identified key treatment windows and outcome measures that will inform the interpretation of clinical trial success.
Researchers at Children's Hospital of Philadelphia found that gene splicing can reduce CD20 protein levels, making immunotherapies ineffective. However, CAR-T cell therapy may still be effective against patients with low CD20 levels, offering a new treatment option for these patients.
A new study by Children's Hospital of Philadelphia found that virtual driving assessments can predict crash risk in newly licensed young drivers. Drivers with major issues on the VDA had an 11% higher crash risk, while those with no issues had a 10% lower risk.
Researchers from CHOP and the University of Pennsylvania found that teenagers living in lower-income areas are up to four times less likely to complete driver training and obtain their license before age 18. Long travel times to driving schools also impacted enrollment, affecting those from both high- and low-income areas.
A small molecule drug improved the fitness of hematopoietic stem cells used in cell transplants, potentially enhancing the success of procedures like ex vivo gene therapy. The study found that targeting extracellular vesicles relieved stress on cells outside the body, improving their performance when transplanted back in.
Researchers found college athletes who experienced non-sports-related concussions had worse symptoms and more days in sports lost to injury. Female athletes had more severe symptoms than male athletes, highlighting the need for improved concussion recognition and monitoring outside of sports.
Researchers from Children's Hospital of Philadelphia developed a noninvasive MRI method for adult zebrafish, capturing high-resolution images of organs. The study found significant brain growth in zebrafish with SURF1 gene deficiency and smaller heart and spinal cord volumes.
Researchers at Children's Hospital of Philadelphia developed TEQUILA-seq, a cost-effective technology for targeted long-read RNA sequencing. This innovation enables accurate accounting of all RNA molecules emanating from a single gene, crucial for understanding diseases like cancer.
A study by Children's Hospital of Philadelphia found that COVID-19 affects mitochondrial function in multiple organs beyond the lungs, leading to long-term damage. Mitochondrial gene expression was suppressed in the heart, kidneys, and liver, while recovering in the lungs.
CHOP and Penn Medicine researchers have developed a proof-of-concept model for delivering gene editing tools directly into diseased blood cells within the body. This approach aims to reduce costs and increase access to gene therapies for blood disorders, which currently require chemotherapy and stem cell transplants.
The study used electronic health record data from over 200,000 children to describe patterns of pediatric allergies across the US, validating the 'allergic march' pattern. It also found that eosinophilic esophagitis (EoE) is more common among non-White patients than previously reported.
Researchers from Children's Hospital of Philadelphia have developed an algorithm to help predict Alzheimer's disease risk based on genetic information in patients with various ethnic backgrounds. The tool, called genomic informed risk assessment (GIRA), was tested in different ethnic populations and performed better than existing methods.
Researchers at Children's Hospital of Philadelphia found that NSAIDs exacerbate C. difficile infections by disrupting epithelial cell mitochondria, sensiting them to toxins. The study shows that NSAIDs and C. difficile toxins work synergistically to increase virulence, leading to increased disease severity and mortality.
Researchers from CHOP and Penn found that cancer patients who continued to smoke after diagnosis were more likely to receive tobacco treatment when nudges were directed at clinicians through electronic health records. This study strengthens the case for using behavioral economics to improve outcomes for cancer patients.
A recent study found that LGB youth experience more interpersonal discrimination and are four times more likely to attempt suicide. Structural stigma also plays a significant role in their mental health burden. The study highlights the need for targeted interventions against discrimination and awareness of structural stigma
A recent survey of caregivers found that most support education efforts and technology use to reduce heatstroke risk, but negative attitudes towards those who put children at risk may hinder mitigation efforts. The study aims to inform the development of pediatric vehicular heatstroke prevention strategies.
CHOP researchers have developed stable, universal MHC-I molecules that can be produced rapidly at scale, allowing for the development of effective and universal immunotherapies. These engineered MHC-I molecules promote peptide exchange across multiple HLA allotypes, covering various forms.
A new study by Children's Hospital of Philadelphia found that the quality of life and self-esteem of children with short stature are associated with coping skills and social supports, rather than their height. The researchers suggest that addressing short stature through a broader, psychosocial approach might have a more positive impac...
CHOP researchers used deep sequencing to discover several previously undescribed genetic variants in vascular anomalies, capturing low-frequency mutations that were missed by conventional methods. The study found significant improvements in symptoms for over 63% of patients, enabling targeted therapies and improved quality of life.
Researchers have created an open-source, reproducible analysis platform for pediatric brain tumors, providing a cloud-based resource for comprehensive data on the disease. The platform contains genomic and clinical data from over 1,000 pediatric brain tumors and 22 patient-derived cell lines.
Researchers found variability in IgA levels between blood and gut samples, suggesting IgA regulates commensal microbes to prevent immune dysregulation. Patients with normal fecal IgA were less likely to develop symptoms, while those deficient in both blood and fecal IgA showed elevated inflammatory cytokines.
Researchers from Children's Hospital of Philadelphia found that repeated soccer headers equivalent to a throw-in did not cause immediate neurophysiological deficits for teens. However, oblique headers resulted in higher levels of angular head motion, suggesting proper training is necessary to reduce the risk of injury.
Researchers developed a computational platform called IRIS to discover tumor antigens from alternative RNA splicing, expanding cancer immunotherapy targets. Hundreds of predicted TCR targets were found to be presented by human leukocyte antigen molecules.
A novel genetic disorder has been identified in 21 patients from around the world, characterized by neurodevelopmental and craniofacial symptoms. The disorder is caused by rare variants in the MAP4K4 gene, which is involved in multiple signaling pathways, including the RAS pathway.
Researchers found that starting early intervention coaching at 18 months old led to greater gains in language, social communication, and daily living skills compared to waiting until 27 months. The study provided high-quality evidence for earlier intervention and highlights the importance of screening for autism at 18 months.
A recent study led by Children's Hospital of Philadelphia identifies two different regulatory T cell populations, one related to autoimmunity and the other to protective immunity. The findings could pave the way for new treatments that target the immune system selectively.
Researchers analyzed 1.5 million patients with 53 million electronic notes to identify 9,477 distinct phenotypes and demonstrated a high degree of agreement with expert judgment in various clinical fields.
Researchers at Children's Hospital of Philadelphia discovered that viral proteins use phase separation to coordinate the complex process of replicating viral genomes and then encapsulating them in a viral particle. This process allows for the orderly and coordinated formation of infectious viral offspring.
Researchers have shown lorlatinib to be safe and effective in treating high-risk neuroblastoma with ALK gene mutations. The targeted therapy has led to a major amendment in a phase 3 clinical trial, offering new hope for patients with this often lethal cancer.
Researchers from CHOP developed a prediction model that determines which newborn babies are likely to experience seizures in the NICU. The model, built using machine learning methods, can predict seizures with over 90% accuracy, particularly in newborns with hypoxic-ischemic encephalopathy.
CHOP researchers found that adolescents with strong relationships with their parents have improved mental and physical health, lower substance use, and higher relationship satisfaction. The study analyzed data from over 15,000 participants and controlled for various factors.
More than half of all reported poisonings affect children ages 5 and younger, with opioids responsible for over half of fatal poisonings. Opioids have contributed to a significant increase in child poisoning deaths despite regulation measures.
CHOP researchers have identified variants of a chaperone molecule that can enhance the loading of peptides across different HLA types, which could be used in cell therapy and immunization applications. The study found that chicken-derived TAPBPR proteins can react with multiple HLA allotypes and stabilize the empty MHC-I groove, boosti...
Researchers at Children's Hospital of Philadelphia developed two new zebrafish models for studying SURF1 mitochondrial disease, a major cause of Leigh syndrome. The team identified two drugs, cysteamine bitartrate and N-acetylcysteine, that showed potential in preventing neurological decompensation in patients with Leigh syndrome.